EPI Review- 2013 MOH Area:…………………………….. Background information 1-MOH area 2-DPDHS area 3-Estimated Population for the year 2013 4-Actual Population for.

Slides:



Advertisements
Similar presentations
Womens Questionnaire TETANUS TOXOID MODULE. Goals and Targets MDG 5: Reduce by three quarters the maternal mortality ratio Strategy: Elimination of maternal.
Advertisements

Under-5 Questionnaire Immunization Module. Global proportion of one year old children vaccinated against measles; Source: WHO UNICEF National.
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Questionnaire for Children Under Five: Immunization.
Training for rotavirus vaccine introduction
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Communicable Diseases & Vaccinations
The Expanded Programme on Immunization in Thailand Pornsak Yoocharoen, MD. Bureau of General Communicable Disease, DDC, MOPH The implications for The border.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Expert Review Committee Meeting March  Recent Nigeria cold chain assessments and EPI committee recommendations ◦ Review wastage rates and further.
Plan For Routine EPI Outreach vaccination Situation Analysis Establishment of objectives Assessment of resources/Fixing priorities Develop and Implement.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
School Based Immunization Campaign
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Health indicators. 2 Absolute indicators ( indices ) :. A ) Morbidity statistics B ) Mortality statistics C )Population ( annual ) growth rate Relative.
Uses of Population Censuses and Household Sample Surveys for Vital Statistics in South Africa United Nations Expert Group Meeting on International Standards.
Tracking of Pregnant Women & Children
Cold Chain Surveillance Coordinator Provincial EPI cell.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
Goal 4: Reduce child mortality Existing Target 5 Reduce by two thirds between 1990 and 2015 the Under Five Mortality Rate Proposed Target 5 Reduce by.
Varicella Zoster Virus Herpesvirus (DNA) Primary infection results in varicella (chickenpox) Recurrent infection results in herpes zoster (shingles) Short.
The Expanded Program On Immunization (EPI). Bacille Calmette-Guérin (BCG) Vaccine: Live attenuated vaccine Store at 0° to 8°C Age : at birth or 6 weeks.
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Pediatric Immunization (EPI) Garcia, Garzon, Gaspar, Gatchalian, Gaw, Geraldoy, Geronimo, Geronimo, Geronimo.
Case Series of HIV-infected children with Bacillus Calmette-Guérin Vaccine Related Lymphadenopathy in Lilongwe, Malawi John Midturi Kazembe, PN., Schutze,
Expanded Program of Immunization Dr. Faten M. Rabie.
Immunization service delivery – immunization management prospective.
Microplanning for Routine Immunization
30th anniversary of starting EPI
EPI Review MOH Area:…………………………….. Background information 1-MOH area 2-DPDHS area 3-Estimated Population for the year Actual Population for.
EPI Review MOH Area:…………………………….. Background information 1-MOH area 2-DPDHS area 3-Estimated Population for the year Actual Population for.
EPI VACCINES. BCG ( Bacille Calmette- Guerin)  Protects infants against TB  In powder form with diluents  Must be discarded after 6 hrs. or at the.
EPI Review RDHS Area:…………………………….. Background information 1-RDHS area 2-Estimated Population for the year Actual Population for the year.
The Cold Chain. Definition Vaccines are sensitive to heat and freezing and must be kept at the correct temperature from the time they are manufactured.
EPI program in MLU/MRML camp MS. Wiphan Kaloy RCH Coordinator.
Measles elimination Dr. As’ad Ramlawi Palestine..
Health indicators Prof. Ashry Gad Mohamed Dr. Salwa Tayel Department of family and Community Medicine.
Dr, Janbaz Afridi Deputy Director EPI Khyber Pakhtunkhwa
The changing vaccination landscape and the sources of vaccination data
Global Training Network ProgrammeWorld Health Organization A medical incident that takes place after an immunization, causes concern, and is believed to.
Reporting on Vaccination Coverage Technical Consultation on Vaccination Data in Household Surveys July 23-24, 2015 Trevor Croft, ICF International.
SERVICE OUTPUTS IN DISTRICT XYZ WITH A POPULATION OF 100, 000 TOTAL OPD: 40,000 FEMALE OPD:14,000 OPD OF WOMEN 15-49YR:5,000 FP CLIENTS (FEMALE): 800 TOTAL.
Expanded program of Immunization (EPI) Introduction The Expanded Program on Immunization (EPI) was established in 1974 depending on the success of the.
DHS, MICS, and EPI Surveys: An Overview of Information Captured.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Primary Health Care Nursing (NUR 473)
Expanded Program of Immunization (EPI). Definition It is program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.
1 EPI services for migrant populations in Tak province.
INTRODUCTION TO INFORMATION SYSTEMS FOR IMMUNIZATION SERVICES IPV Global Workshop March 2014.
Core Topic 11 Documentation, record keeping and reporting.
The Norwegian Immunisation Registry - SYSVAK Maria Hagerup-Jenssen Senior Adviser Norwegian Institute of Public Health Istanbul 11th of November 2014.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
FY 2016 GPRA/GPRAMA update: CA Urban December 2015.
Cold Chain System.
Chapter 2. **The frequency distribution is a table which displays how many people fall into each category of a variable such as age, income level, or.
Maternal and Neonatal Tetanus Elimination (MNTE) in Kenya Dr Collins Tabu, National Vaccines and Immunization Program Ministry of Health, Kenya.
EPI and VPD Review MOH Area:…………………………….. Background information 1-MOH area 2-RDHS area 3-Estimated Population for the year Actual Population.
1 Dr. Vidumini De Silva. Describe the current schedule for the Expanded Programme on Immunization (EPI) 2.
Mumps Outbreaks Associated with Correctional Facilities Texas
MATERNAL AND CHILD HEALTH INDICATORS
Immunization.
World Health Organization
Recording and monitoring uptake of JE vaccine
Training for rotavirus vaccine introduction
World Health Organization
Provincial Measles Immunization Catch-Up Program
Training for rotavirus vaccine introduction
Training for rotavirus vaccine introduction
Presentation transcript:

EPI Review MOH Area:…………………………….

Background information 1-MOH area 2-DPDHS area 3-Estimated Population for the year Actual Population for the year Reasons for differences in actual and estimated populations 6-Crude Birth Rate for District Crude Birth Rate for Province Estimated Number of Births in the year 2013 Based on the Actual Population Based on the Estimated Population District BR Provincial BR 9-Number of Immunizations performed in the year 2013 (institutions and field) (Sum of relevant data from four Q/ EPI returns, 2013) PVV1PVV2PVV3 10-Number of pregnant mothers registered for the area in Number of actual births reported for the area in Number of infants registered for the area in The most probable number of births for the MOH area*

Background information……cont Approved number Number available Average Population covered by each category / clinic Population Range 12-PHMs 13-PHIs 14-SPHMs 15-PHNS 16-SPHI 17-MOHs/AMOHs 18. MCH Clinics

Area Map indicating access to immunization (Please present a map indicating immunization clinics and population served by each clinic )

Coverage of BCG vaccination among infants born between 1 st of January 2013 to 31 st of December 2013 and the protection of their mothers from Tetanus and Rubella vaccination at the time of delivery Vaccine(AA) Number of pregnant mothers registered in year 2012 (A) Number of registered infants under care * (B) Number of estimated births for 2013 (C) Number of vaccinations according to BI registers/pregn ant mother registers /mothers cards (D) Number & % of age appropriate vaccinations according to BI registers** (E) Number of vaccines given according to Q/ EPI return Coverage according to Registered infants under care * Estimated births FORMULA (D/A)*100(C/A)* 100(C/B)* 100 BCG TT*** Rubella*** Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of January 2013 to 31 st of December 2013 Registered within 3 months of birth (V)**** Registered after 3 months of birth to date^^ (W)**** Came newly into the area & registered to date^^ (X) Left the area to date^^ (Y) Died to date^^ (Z)

Coverage of OPV1 /PVV 1 vaccination among infants born between 01 st of November 2012 to 31 st of October 2013 Vaccine (AA) Number of pregnant mothers registered in year 2012 (A) Number of registered infants under care* (B) Number of estimated births For 2013 (C) Number of vaccinations according to BI registers (D) Number & % of age appropriate vaccinations according to BI registers* * (E) Number of vaccines given according to Q/ EPI return Coverage according to Registered infants under care* Estimated births Number of vaccines given as per Q/ EPI return FORMULA (D/A)*100(C/A) *100(C/B) *100(C/E)*100 PVV1 OPV1 Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of November 2012 to 31 st of October 2013 registered within 3 months of birth (V)**** registered after 3 months of birth to date^^ (W)**** came newly into the area registered to date^^ (X) left the area to date^^ (Y) Died to date^^ (Z)

Coverage of LJEV vaccination among infants born between 01 st of April 2012 to 31 st of March 2013 Vaccine (AA) Number of pregnant mothers registered in year 2011 (A) Number of registered infants under care* (B) Number of estimated births For 2012 (C) Number of vaccinations according to BI registers (D) Number & % of age appropriate vaccinations according to BI registers** (E) Number of vaccines given according to Q/ EPI return Coverage according to Registered infants under care* Estimated births Number of vaccines given as per Q/ EPI returns FORMULA (D/A)*100(C/A)* 100(C/B)* 100(C/E) *100 LJEV Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of April 2012 to 31 st of March 2013 registered within 3 months of birth (V)**** registered after 3 months of birth to date^^ (W)**** came newly into the area registered to date^^ (X) left the area to date^^ (Y) Died to date^^ (Z)

Coverage of MMR1 vaccination among infants born between 1 st of January 2012 to 31 st of December 2012 Vaccine (AA) Number of pregnant mothers registered in year 2011 (A) Number of registered infants under care* (B) Number of estimated births For 2012 (C) Number of vaccinations according to BI registers (D) Number & % of age appropriate vaccinations according to BI registers** (E) Number of vaccines given according to Q/ EPI return Coverage according to Registered infants under care* Estimated births Number of vaccines given as per Q/ EPI returns FORMULA (D/A)*100(C/A) *100(C/B) *100(C/E) *100 MMR1 Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of January 2012 to 31 st of December 2013 registered within 3 months of birth (V)**** registered after 3 months of birth to date^^ (W)**** came newly into the area registered to date^^ (X) left the area to date^^ (Y) Died to date^^ (Z)

Coverage of DPT4/OPV4 vaccination among infants born between 1 st of July 2011 to 30 th June 2012 Vaccine(AA) Number of pregnant mothers registered in year 2010 (A) Number of registered infants under care* (B) Number of estimated births 2011 (C) Number of vaccinations according to BI registers (D) Number & % of age appropriate vaccinations according to BI registers* * (E) Number of vaccines given according to Q/ EPI return % Coverage according to Registered infants under care* Estimated births Number of vaccines given as per Q/ EPI returns FORMULA (D/A)*100(C/A)* 100(C/B) *100(C/E)* 100 DPT4 OPV4 Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of January 2011 to 30 th of June 2012 registered within 3 months of birth (V)**** registered after 3 months of birth to date^^ (W)**** came newly into the area registered to date^^ (X) left the area to date^^ (Y) Died to date^^ (Z)

Coverage of MMR2 vaccination among infants born between 1 st of January 2010 to 31 st of December 2010 Vaccine (AA) Number of pregnant mothers registered in year 2009 (A) Number of registered infants under care* (B) Number of estimated births 2010 (C) Number of vaccinations according to BI registers (D) Number & % of age appropriate vaccinations according to BI registers* * (E) Number of vaccines given according to Q/ EPI return Coverage of according to Registered infants under care* Estimated births Number of vaccines given as per Q/ EPI returns FORMULA (D/A)*100(C/A)* 100(C/B) *100(C/E) *100 MMR2 Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of January 2010 to 31 st of December 2010 registered within 3 months of birth (V)**** registered after 3 months of birth to date^^ (W)**** came newly into the area registered to date^^ (X) left the area to date^^ (Y) Died to date^^ (Z)

Coverage of DT/OPV5 vaccination among infants born between 1 st of January 2008 to 31 st of December 2008 Vaccine(AA) Number of pregnant mothers registered in year 2007 (A) Number of registered infants under care * (B) Number of estimated births for 2008 (C) Number of vaccinations according to BI registers (D) Number & % of age appropriate vaccinations according to BI registers* * (E) Number of vaccines given according to Q/ EPI return % Coverage according to Registered infants under care* Estimated births Number of vaccines given as per Q/ EPI returns FORMULA (D/A)*100(C/A)* 100(C/B)* 100(C/E) *100 DT OPV5 Number of registered infants under care* (A) A = (V+W+X) - (Y+-Z) Number of infants born between 1 st of January 2008 to 31 st of December 2008 registered within 3 months of birth (V)**** registered after 3 months of birth to date^^ (W)**** came newly into the area registered to date^^ (X) left the area to date^^ (Y) Died to date^^ (Z)

VaccinePHMM areas with low immunization coverage (%) according to estimated births registered infants under care age appropriate immunizations PHM area% % % BCG TT( Maternal) Rubella(Maternal) PVV1/OPV1 LJEV MMR1 DPT4/OPV4 MMR2 DT/OPV5 PHM areas with low immunization coverage (Please include the data for the 3 PHMM areas where the lowest immunization coverages have been reported under each category )

Coverage of aTd vaccination among school children in grade 7 during 2013 by PHI areas NoPHI areaNumber on roll in grade 7 Number of children immunized in grade 7 % of immunized children in grade 7 Number of children immunized in other grades Total number immunized in year Total

Comparison of coverage’s of antigens according to the advancing birth cohorts Vaccine(AA) Number of pregnant mothers registered in respective years (A) Number of registered infants under care *( for respective birth cohorts under review ) (B) Number of estimated births ( for respective birth cohorts under review ) (C) Number of vaccinations given according to BI registers (D) Number of DPT 1 doses given according to Q/ EPI return for the years of respective birth cohorts under review (E) Number of vaccines given according to Q/ EPI returns 2013 % Coverage according to Registered births (C/A) *100 Estimated births (C/B)* 100 Number of vaccines given as per Q/ EPI returns for the years of respective birth cohorts under review (C/E)* 100 YEAR No. of doses BCG 2013 PVV1 2012( 4Q) 2013( 1,2,3 Q) LJEV 2012-(2,3,4 Q) 2013– (1Q) MMR DPT (3,4 Q) 2012-(1.2 Q) MMR DT 2008 aTd

Number of immunizations performed and difference against the antigen which ever has the highest number of immunizations(PVV1, PVV2, PVV3) during infancy ( 1 st year of life) in MOH area by antigen in 2013

Antigen Book balance as of 31 st December 2012 (A) Total receipts during 2013 (B) Book balance as of 31 st of December 2013 (C ) No of doses discarde d due to expiry or cold chain failure during 2013 (D) Total number of doses used during 2013 for vaccination ( E)= (A+B)-(C +D) Highest book balance in a given time during the year 2013 (F) No. of Immunizations Performed by clinics/ schools/ estates/GPs ( Based on the four EPI quarterly Returns for year 2013) ( G ) No. of doses Distributed to Clinics/schools /GPs (Based on the MOH Office vaccine movement register for year 2013) ( H ) Usage % ( I )= G/E * 100 Wastage % ( J )= (100- I ) B.C.G Penta DPT OPV LJEV DT TT aTd MMR Other Form 11 Status of vaccine wastage in the MOH area by antigen in 2013

Adverse events following immunization (A.E.F.I.) No. of Monthly AEFI Returns expected to be sent to the Epidemiological Unit during No. of Monthly AEFI Returns sent No. of Monthly AEFI Returns sent in time No of “Nil” returns sent Type of AEFINumber ReportedNo Investigated% Investigated Injection site abscess BCG lymphadenitis Severe local reactions Encephalitis/Encephalopathy Meningitis Seizures (Febrile + Afebrile) Anaphylaxis Persistent Screaming HHE Types of AEFIs reported during 2013

AntigenType of AEFINumber of AEFI Reported (A) No of doses administered† (B) AEFI Rate ( C ) (C =(A)/(B)* National Rates for 2013 BCGBCG lymphadenitis PentaSeizures (Febrile + Afebrile) Anaphylaxis Persistent Screaming HHE Allergic reaction MeaslesSeizures (Febrile + Afebrile) Anaphylaxis Allergic reaction MMRSeizures (Febrile + Afebrile) Anaphylaxis Allergic reaction Parotitis JESeizures (Febrile + Afebrile) Anaphylaxis Allergic reaction Encephalitis/Encephalop athy Meningitis Other* Rates of AEFIs reported during 2013

Information regarding cold chain equipment in MOH office in 2013 Please bring the temperature charts and printouts of data lodger recordings for year 2013 to the review. Refrigerator Working order (Yes/No) Year of manufacture Capacity (liters) Thermometer in working Order (Yes/No) Data lodger in working Order (Yes/No) Temp. Chart maintained daily during the reporting period (12 months) (Yes/No) Refrigerator 1 Refrigerator 2 Freezer 1Were there any cold chain breakdowns during the reporting period? (If yes, please describe such situations) 2Who is in charge of the refrigerator and vaccine? 3Who is in charge of the daily recording of temperature? 4How often data lodger printout are being taking? 6How many print outs available in the file for the year under review? 7Were there situations vaccines exposed to sub zero temperatures? 8Were there any mismatch in temperature recordings and data lodger recordings? (If yes, please describe such situations with possible reasons)

Calculation of minimum refrigerator capacity required for storage of vaccines for MOH area Vaccine (A) Average monthly consumption* (B) Maximum No. of doses to be retained in the refrigerator at a given time (C) = (B) X 2 Volume per dose in cm3 (D) Volume required for storing maximum number of doses at a given time in cm3** (E) (E)=(C )X ( D) BCG1.2 BCG diluents0.6 DPT3.0 PVV19.4 OPV1.5 MMR3.0 MMR diluents 3.06 DT2.0 TT2.5 aTd3.0 JE2.24 JE diluents2.8 TOTAL ………… cm3 Storage volume can be converted from cm3 to liters by dividing by 1000 …………. liters

Incidence of infant deaths, neo natal deaths and their causes – 2013 **Please use national Infant mortality rate (9.0 per 1000 live births) to calculate the estimated number of live births for year 2013 No. Estimated** No. Reported% ReportedNo. Investigated% Investigated No. of live births Infant Deaths Neonatal Deaths Causes 1. Prematurity 2. Congenital Abnormalities No of infant deaths temporally associated with vaccination

Notification and investigation of EPI target diseases DiseaseNo. Reported (A) No. Investigated* (B) No, confirmed (C) % Investigated (D) (D)=(B)/(A)*100 No. of special investigation forms sent (E) % of special investigation forms sent (F) (F)=(E)/(C)*100 Whooping Cough Tetanus NNT Measles Rubella CRS AFP Encephalitis Meningitis Mumps Total